Eine Plattform für die Wissenschaft: Bauingenieurwesen, Architektur und Urbanistik
Eine Plattform für die Wissenschaft: Bauingenieurwesen, Architektur und Urbanistik
Cell Death Pathway Regulation by Functional Nanomedicines for Robust Antitumor Immunity
Cancer immunotherapy has become a mainstream cancer treatment over traditional therapeutic modes. Cancer cells can undergo programmed cell death including ferroptosis, pyroptosis, autophagy, necroptosis, apoptosis and cuproptosis which are find to have intrinsic relationships with host antitumor immune response. However, direct use of cell death inducers or regulators may bring about severe side effects that can also be rapidly excreted and degraded with low therapeutic efficacy. Nanomaterials are able to carry them for long circulation time, high tumor accumulation and controlled release to achieve satisfactory therapeutic effect. Nowadays, a large number of studies have focused on nanomedicines‐based strategies through modulating cell death modalities to potentiate antitumor immunity. Herein, immune cell types and their function are first summarized, and state‐of‐the‐art research progresses in nanomedicines mediated cell death pathways (e.g., ferroptosis, pyroptosis, autophagy, necroptosis, apoptosis and cuproptosis) with immune response provocation are highlighted. Subsequently, the conclusion and outlook of potential research focus are discussed.
Cell Death Pathway Regulation by Functional Nanomedicines for Robust Antitumor Immunity
Cancer immunotherapy has become a mainstream cancer treatment over traditional therapeutic modes. Cancer cells can undergo programmed cell death including ferroptosis, pyroptosis, autophagy, necroptosis, apoptosis and cuproptosis which are find to have intrinsic relationships with host antitumor immune response. However, direct use of cell death inducers or regulators may bring about severe side effects that can also be rapidly excreted and degraded with low therapeutic efficacy. Nanomaterials are able to carry them for long circulation time, high tumor accumulation and controlled release to achieve satisfactory therapeutic effect. Nowadays, a large number of studies have focused on nanomedicines‐based strategies through modulating cell death modalities to potentiate antitumor immunity. Herein, immune cell types and their function are first summarized, and state‐of‐the‐art research progresses in nanomedicines mediated cell death pathways (e.g., ferroptosis, pyroptosis, autophagy, necroptosis, apoptosis and cuproptosis) with immune response provocation are highlighted. Subsequently, the conclusion and outlook of potential research focus are discussed.
Cell Death Pathway Regulation by Functional Nanomedicines for Robust Antitumor Immunity
Li, Yongjuan (Autor:in) / Guo, Yichen (Autor:in) / Zhang, Kaixin (Autor:in) / Zhu, Rongrong (Autor:in) / Chen, Xiaoyuan (Autor:in) / Zhang, Zhenzhong (Autor:in) / Yang, Weijing (Autor:in)
Advanced Science ; 11
01.01.2024
23 pages
Aufsatz (Zeitschrift)
Elektronische Ressource
Englisch
Cell Death Pathway Regulation by Functional Nanomedicines for Robust Antitumor Immunity
| Wiley | 2024
Chemistry of Advanced Nanomedicines in Cancer Cell Metabolism Regulation
| Wiley | 2020
Interfaces in Multiphase Polymers and Nanomedicines
| British Library Online Contents | 2012
Engineering Versatile Nanomedicines for Ultrasonic Tumor Immunotherapy
| Wiley | 2024